Loading...
•
Mar 31, 2025
Alphatec Q1 2025 Earnings Report
Estimated Revenue:$168M
+27.9% YoY
Estimated EPS:-$0.119
+64.7% YoY
Key Takeaways
Alphatec Holdings, Inc. reported strong financial results for the first quarter of 2025, with total revenue increasing by 22% and surgical revenue growing by 24%. The company also raised its full-year revenue and profitability guidance.
Total revenue reached $169 million in Q1 2025, a 22% increase year-over-year.
Surgical revenue grew 24% to $152 million, driven by a 17% increase in procedural volume.
Achieved an 18% growth in new surgeon adoption.
Improved Adjusted EBITDA margin by 840 bps year-over-year to 6.2%.
Revenue by Segment
Forward Guidance
For the full fiscal year 2025, the company updated its guidance, expecting total revenue to grow 20% to $734 million and non-GAAP adjusted EBITDA to be approximately $78 million.
Positive Outlook
- Increased full-year total revenue guidance to $734 million, up from $732 million.
- Increased full-year non-GAAP adjusted EBITDA guidance to approximately $78 million, up from $75 million.
- Anticipates surgical revenue of $658 million for the full year.
- Anticipates EOS revenue of $76 million for the full year.
- Execution discipline and delivery on financial commitments.
Challenges Ahead
- No explicit negative forward guidance points were mentioned in the provided text.
- Potential risks include uncertainty in developing new products.
- Uncertainties in the ability to execute the strategic operating plan.
- Failure to achieve acceptance of products by the surgeon community.
Loading...
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...